Skip to main content

and
  1. Article

    Open Access

    Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer

    Non-small cell lung cancer (NSCLC) patients with sensitive epidermal growth factor receptor (EGFR) mutations are successfully treated with EGFR tyrosine kinase inhibitors (EGFR-TKIs); however, resistance to tr...

    Quanfu Huang, Qiuguo Wang, Dong Li, **ao Wei in Journal of Experimental & Clinical Cancer … (2019)